订阅小程序
旧版功能

A Multi-Center, Phase Ib Study of Subcutaneous Administration of Isatuximab in Combination with Pomalidomide and Dexamethasone in Patients with Relapsed/refractory Multiple Myeloma

Haematologica(2024)

引用 0|浏览0
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要